Ecolab Inc. – Consensus Indicates Potential 10.4% Upside
Ecolab Inc. with ticker code (ECL) now have 18 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The range between the high target price and low target price is between 198 and 163 with the average target price sitting at 179.33. Given that the stocks previous close was at 162.4 this would imply there is a potential upside of 10.4%. The 50 day moving average now sits at 163.21 and the 200 moving average now moves to 182.12. The market cap for the company is $46,066m. Visit the company website at: https:||www.ecolab.com [stock_market_widget type="chart" template="basic" color="green" assets="ECL" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $50,868m based on the market concensus. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional Specialty, and Global Healthcare Life Sciences segments.
Ecolab Inc. – Consensus Indicates Potential 10.4% Upside
Ecolab Inc. with ticker code (ECL) now have 18 analysts covering the stock with the consensus suggesting a rating of ''Hold''. The range between the high target price and low target price is between 198 and 163 with the average target price sitting at 179.33. Given that the stocks previous close was at 162.4 this would imply there is a potential upside of 10.4%. The 50 day moving average now sits at 163.21 and the 200 moving average now moves to 182.12. The market cap for the company is $46,066m. Visit the company website at: https:||www.ecolab.com [stock_market_widget type="chart" template="basic" color="green" assets="ECL" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $50,868m based on the market concensus. Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional Specialty, and Global Healthcare Life Sciences segments.